ArticleRSC advances2026
A new approach for the ultra-high loading of curcumin onto a nano-sized ZIF-68 as an effective drug delivery system with good biocompatibility and efficient anti-cancer therapy.
Article in RSC advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Curcumin-Loaded Cellulose Nanofibers for Breast Cancer Therapy: A Multiscale Computational and Experimental Evaluation.International journal of nanomedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Recently, metal-organic frameworks have become well-known as promising drug carrier systems for anticancer treatment. However, their performances are inadequate for real-life situations due to the uncontrolled drug release rate and lack of strong interactions between the backbone and guest molecules. To overcome these challenges, a nano-sized zeolite imidazole framework-68 was successfully prepared, denoted as ZIF-68, through the solvothermal technique, and demonstrated an extraordinary potential for curcumin (Cur) uptake. As a consequence, the maximum adsorption capacity and drug loading content of Cur over ZIF-68 reached 720.1 mg g
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.